Gland Pharma Ltd reports Q2 FY27 revenue of ₹1,833.6 crore, up 23% YoY
- EBITDA margin was 26%, versus 21% in Q2 FY26 and 27% in Q1 FY27.
- Net profit was ₹290.8 crore, up 58% YoY and down 8% sequentially.
- Presentation reported no exceptional items or auditor qualifications.
